Government offers drug firms ₹3,501 crore settlement for price cap penalties3 min read . Updated: 09 May 2019, 01:23 AM IST
- DoP will waive interest amount of ₹1,325 cr if the firms drop cases against its order
- There are 666 cases where DoP has asked firms to disgorge excess profits because of non-compliance with govt orders
NEW DELHI : The government has offered a one-time waiver of interest charges if drug makers, including Sun Pharmaceuticals Industries Ltd, Pfizer Ltd and Lupin Ltd, agree to deposit more than ₹3,501 crore they collected by selling drugs at prices higher than those notified by the drug pricing regulator.
Select your Category